tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL
Advertisement

AbCellera Biologics (ABCL) Revenue

Compare
2,062 Followers

AbCellera Biologics Revenue

AbCellera Biologics had a revenue of 17.08M in the quarter ending Jun 30, 2025, with 303.40%. This bring the company's revenue in the last twelve months to 32.88M, Decreased 42.23%. In the fiscal year ending Dec 31, 2024, AbCellera Biologics had annual revenue of 28.83M with -24.17% growth.
Revenue (ttm)
32.88M
Revenue Growth
-0.54%
P/S Ratio
43.74
Revenue/Employee
$48,378
Employees
596
Market Cap
$1.26B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
28.83M-9.19M-24.17%
Dec 31, 2023
38.02M-447.40M-92.17%
Dec 31, 2022
485.42M110.22M+29.38%
Dec 31, 2021
375.20M142.05M+60.92%
Dec 31, 2020
233.16M221.54M+1,907.96%
Dec 31, 2019
11.61M2.78M+31.49%
Dec 31, 2018
8.83M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis